French Vaccine Co. Valneva Raises €103M In Global Offering
By Najiyya Budaly ( October 5, 2022, 3:03 PM BST) -- Valneva has said that it has raised €102.9 million ($102 million) through a global offering to U.S. and European investors to help the French company develop and market its vaccine candidates....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.